Stockreport

Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook [Yahoo! Finance]

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK) 
PDF Core Operating Profit Increase of +12.9% at CER; Core Operating Profit Margin of 30.2% Double-Digit Revenue Growth of ENTYVIO ® at CER Driven by Launch of ENTYVIO ® P [Read more]